These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10365753)

  • 1. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation.
    Léon C; Vial C; Gachet C; Ohlmann P; Hechler B; Cazenave JP; Lecchi A; Cattaneo M
    Thromb Haemost; 1999 May; 81(5):775-81. PubMed ID: 10365753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation by ADP: the role of ADP antagonists.
    Gachet C
    Ann Med; 2000 Dec; 32 Suppl 1():15-20. PubMed ID: 11209975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
    Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intracellular signaling events in ADP-induced platelet aggregation.
    Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
    Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
    Packham MA; Mustard JF
    Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
    Jin J; Daniel JL; Kunapuli SP
    J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The P2Y1 receptor is essential for ADP-induced shape change and aggregation in mouse platelets.
    Kim YB; Jin J; Dangelmaier C; Daniel JL; Kunapuli SP
    Platelets; 1999; 10(6):399-406. PubMed ID: 16801119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.
    Fabre JE; Nguyen M; Latour A; Keifer JA; Audoly LP; Coffman TM; Koller BH
    Nat Med; 1999 Oct; 5(10):1199-202. PubMed ID: 10502826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP receptors of platelets and their inhibition.
    Gachet C
    Thromb Haemost; 2001 Jul; 86(1):222-32. PubMed ID: 11487010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
    Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
    Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The P2 receptors and congenital platelet function defects.
    Cattaneo M
    Semin Thromb Hemost; 2005 Apr; 31(2):168-73. PubMed ID: 15852220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2Y12, a new platelet ADP receptor, target of clopidogrel.
    Herbert JM; Savi P
    Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
    Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
    J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism.
    Hardy AR; Hill DJ; Poole AW
    Platelets; 2005 Nov; 16(7):415-29. PubMed ID: 16236603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.
    Hechler B; Léon C; Vial C; Vigne P; Frelin C; Cazenave JP; Gachet C
    Blood; 1998 Jul; 92(1):152-9. PubMed ID: 9639511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADP-induced platelet activation.
    Puri RN; Colman RW
    Crit Rev Biochem Mol Biol; 1997; 32(6):437-502. PubMed ID: 9444477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
    Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
    Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
    Gachet C
    Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.